ResourcesWhen Safety-Net Programs Compete: Medicaid, 340B, And the Battle Over Drug Discounts Resources / healnetwork1
ResourcesFinancial Outcomes and Community Benefit in the 340B Program: Comparing 340B and Non-340B Hospitals Resources / healnetwork1
ResourcesWhen Lower Prices Don’t Mean Lower Costs: How Part D Benefit Changes Are Shifting Out-of-Pocket Spending in 2026 Under the Inflation Reduction Act Resources / healnetwork1
ResourcesIncreasing Payer Control for Medicare Patients Initiating Branded Medicines Resources / healnetwork1
ResourcesThe Impact of Intellectual Property Protection on Post-Approval Innovation Resources / healnetwork1
ResourcesHow PBMs’ Vertically Affiliated Pharmacies Shape Access Pathways for Oncology and Autoimmune Patients Resources / healnetwork1
Report, ResourcesDisaggregating Innovation: Labor Productivity Gains from Biologic vs. Small Molecule Drugs and Implications of U.S. Drug Pricing Policy Report, Resources / healnetwork1
